Amneal Pharmaceuticals
AMRX
6,75 €
Share price
-0.38%
Change (1 day)
3.05%
Change (1 year)
Categories
EPS for Amneal Pharmaceuticals (AMRX)
EPS in 2025 (TTM): -0,04094 €
According to Amneal Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -0,03512 €. In 2024 the company made an earnings per share (EPS) of -0,33 € a decrease over its 2023 EPS that were of -0,27 €.
EPS history for Amneal Pharmaceuticals from 2018 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | -0,04094 € | -87.59% |
| 2024 | -0,33 € | 22.74% |
| 2023 | -0,27 € | -63.95% |
| 2022 | -0,75 € | -1175% |
| 2021 | 0,06936 € | -87.1% |
| 2020 | 0,54 € | -122.46% |
| 2019 | -2,39 € | 1523.53% |
| 2018 | -0,15 € |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | -0,82 € | 2,245.45% | 🇺🇸 USA |
 OPKO Health
OPK | -0,04335 € | 23.44% | 🇺🇸 USA |